ChatGPT can help guide and empower patients after prostate cancer diagnosis

被引:2
|
作者
Collin, Harry [1 ,2 ]
Keogh, Kandice [1 ,2 ]
Basto, Marnique [1 ]
Loeb, Stacy [3 ,4 ]
Roberts, Matthew J. [1 ,5 ]
机构
[1] Royal Brisbane & Womens Hosp, Dept Urol, Brisbane, Qld, Australia
[2] Univ Queensland, Fac Med, Brisbane, Qld, Australia
[3] New York Univ Langone Hlth, Dept Urol, New York, NY USA
[4] New York Univ Langone Hlth, Dept Populat Hlth, New York, NY USA
[5] Univ Queensland, Ctr Clin Res, Brisbane, Qld, Australia
关键词
D O I
10.1038/s41391-024-00864-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/ObjectivesPatients often face uncertainty about what they should know after prostate cancer diagnosis. Web-based information is common but is at risk of being of poor quality or readability.Subjects/MethodsWe used ChatGPT, a freely available Artificial intelligence (AI) platform, to generate enquiries about prostate cancer that a newly diagnosed patient might ask and compared to Google search trends. Then, we evaluated ChatGPT responses to these questions for clinical appropriateness and quality using standardised tools.ResultsChatGPT generates broad and representative questions, and provides understandable, clinically sound advice.ConclusionsAI can guide and empower patients after prostate cancer diagnosis through education. However, the limitations of the ChatGPT language-model must not be ignored and require further evaluation and optimisation in the healthcare field.
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Can a "Prompt List" empower cancer patients to ask relevant questions?
    Dimoska, Aneta
    Tattersall, Martin H. N.
    Butow, Phyllis N.
    Shepherd, Heather
    Kinnersley, Paul
    CANCER, 2008, 113 (02) : 225 - 237
  • [22] Granulomatous Prostatitis, the Great Mimicker of Prostate Cancer: Can Multiparametric MRI Features Help in This Challenging Differential Diagnosis?
    Bertelli, Elena
    Zantonelli, Giulia
    Cinelli, Alberto
    Pastacaldi, Sandro
    Agostini, Simone
    Neri, Emanuele
    Miele, Vittorio
    DIAGNOSTICS, 2022, 12 (10)
  • [23] The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer
    Zheng, Jian
    Ye, Xiong
    Liu, Yanan
    Zhao, Yuxia
    He, Mudan
    Xiao, Hui
    BMC CANCER, 2020, 20 (01)
  • [24] The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer
    Jian Zheng
    Xiong Ye
    Yanan Liu
    Yuxia Zhao
    Mudan He
    Hui Xiao
    BMC Cancer, 20
  • [25] Prostate specific antigen velocity and covariance can help predict the detection of significant prostate cancer after a first negative biopsy
    Benchikh, Amine
    Duhamel, Alain
    Fantoni, Jean-Christophe
    Dubucquoi, Sylvain
    Ballereau, Charles
    Biserte, Jacques
    Villers, Amauld
    JOURNAL OF UROLOGY, 2008, 179 (04): : 638 - 639
  • [26] Can Genomic Data Guide the Postoperative Management of Prostate Cancer?
    Parikh, Rahul R.
    Kim, Isaac Yi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (18) : 1973 - +
  • [27] Prostate volume estimation can significantly improve prostate cancer diagnosis
    Foley, R.
    Murphy, K.
    Lundon, D.
    Durkan, G.
    Power, R.
    Galvin, D.
    Murphy, T. B.
    Watson, R. W.
    BJU INTERNATIONAL, 2015, 116 : 20 - 20
  • [28] Infographics on signs and symptoms of metastatic (secondary) breast cancer can empower women with a breast cancer diagnosis
    Derakshan, Nazanin
    Taylor, Joanne
    Chapman, Bethany
    FRONTIERS IN PSYCHOLOGY, 2024, 15
  • [29] HOW PHYSICIANS CAN HELP THEIR PATIENTS QUIT SMOKING - A PRACTICAL GUIDE
    PROCHAZKA, AV
    BOYKO, EJ
    WESTERN JOURNAL OF MEDICINE, 1988, 149 (02): : 188 - 194
  • [30] Genomic tests to guide prostate cancer management following diagnosis
    Colicchia, Michele
    Morlacco, Alessandro
    Cheville, John C.
    Karnes, R. Jeffrey
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (04) : 367 - 377